TLDR Biotech

𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐚𝐧𝐝 𝐏𝐡𝐚𝐫𝐦𝐚 𝐔𝐩𝐝𝐚𝐭𝐞𝐬: December 18 - 19, 2024 Ottimo Pharma's CEO ready to "have some fun" with $140M Series A, BMS buys two preclinical Alzheimer's antibodies from BioArctic, KdT Ventures launches a currently unnamed rare disease start-up powered by an NGM Bio asset, US government nears shutdown as PBM reform thrown to the wayside + 31 more stories Get the full newsletter on the TLDR Biotech website: https://lnkd.in/gGhR24ja This will be the last TLDR Biotech newsletter of 2024 - we’ll be back in the New Year (probably January 6, 2025). Hoping you all have a wonderful holiday season! ⛄️🎄

𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐚𝐧𝐝 𝐏𝐡𝐚𝐫𝐦𝐚 𝐔𝐩𝐝𝐚𝐭𝐞𝐬: December 17 - 18, 2024 Novartis & AbbVie score a 340B win in West Virginia, FDA approves Mesoblast's allogeneic mesenchymal stromal cell therapy (a US first), Novartis and BioAge Labs partner on age-related disease drug discovery, AstraZeneca likely taking a sales hit in China amid employee investigations + 36 more stories Get the full newsletter on the TLDR Biotech website: https://lnkd.in/g52Hi7XB

𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐚𝐧𝐝 𝐏𝐡𝐚𝐫𝐦𝐚 𝐔𝐩𝐝𝐚𝐭𝐞𝐬: December 16 - 17, 2024 Sandoz pays $275M to settle generic price-fixing litigation, Pfizer forecasts a more stable & upbeat 2025, Akamis Bio's $60M raise fuels oncolytic gene therapy ambitions, The Big Apple gets a CGT manufacturing hub, PBMs (unsurprisingly) fight back against PBM reform + 26 more stories Get the full newsletter on the TLDR Biotech website: https://lnkd.in/gYheVf6n

𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐚𝐧𝐝 𝐏𝐡𝐚𝐫𝐦𝐚 𝐔𝐩𝐝𝐚𝐭𝐞𝐬: December 15 - 16, 2024 Novo Holdings & Catalent deal full steam ahead after FTC ok, Promise Bio launches with AI-driven precision medicine for autoimmune diseases ambitions, Candid Therapeutics signs on trio of bispecific R&D deals, Roche discontinues Ph3 gene therapy asset development + 30 more stories Get the full newsletter on the TLDR Biotech website: https://lnkd.in/g8W7zgbd

𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐚𝐧𝐝 𝐏𝐡𝐚𝐫𝐦𝐚 𝐔𝐩𝐝𝐚𝐭𝐞𝐬: December 12 - 15, 2024 AbbVie to acquire Nimble Therapeutics for $200M, Novavax lands $50M milestone payment related to Sanofi-partnered pediatric COVID-19 vaccine, Turn Therapeutics $75M investment to fuel advanced wound and dermatology ambitions, McKinsey agrees to $650 settlement in Purdue opioid case + 29 more stories Get the full newsletter on the TLDR Biotech website: https://lnkd.in/gSPSMEaF

𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐚𝐧𝐝 𝐏𝐡𝐚𝐫𝐦𝐚 𝐔𝐩𝐝𝐚𝐭𝐞𝐬: December 11 - 12, 2024 Investors sue BMS on alleged reneging on milestone payments, Novo Nordisk's Ozempic lands kidney disease-related label expansion in the EU, Expression Therapeutics has “promising” Ph1 hemophilia A gene therapy data, Keros Therapeutics stock plummets on PAH clinical trial holds due to pericardial effusion cases + 32 more stories Get the full newsletter on the TLDR Biotech website: https://lnkd.in/eFxw9ZnB Related story to below gif: Bristol Myers Squibb allegedly reneged on milestone payments to investors of acquisition Padlock Therapeutics, according to new lawsuit. (Gif source: darenduelas on Giphy)

𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐚𝐧𝐝 𝐏𝐡𝐚𝐫𝐦𝐚 𝐔𝐩𝐝𝐚𝐭𝐞𝐬: December 10 - 11, 2024 Pair of (former) biotech CEOs convicted of fraud, Candel Therapeutics stock jumps on positive viral immunotherapy Ph3 data in prostate cancer, Angitia Biopharmaceuticals $120M Series C targeting musculoskeletal disorders, Q32 Bio stock collapses on "messy" trial results + 37 more stories Get the full newsletter on the TLDR Biotech website: https://lnkd.in/gB2MDB5H

𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐚𝐧𝐝 𝐏𝐡𝐚𝐫𝐦𝐚 𝐔𝐩𝐝𝐚𝐭𝐞𝐬: December 9 - 10, 2024 uniQure stock skyrockets on clear(er) path to accelerated approval, BioNTech's breast cancer bispecific dreams of dethroning Keytruda, Tasca Therapeutics launches with $52M to discover novel lipid-bound protein pockets, GSK and Relation partner on fibrotic disease and osteoarthritis drug discovery + 33 more stories Get the full newsletter on the TLDR Biotech website: tldrbio[DOT]tech/p/biotech-pharma-updates-december-9-10-2024

𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐚𝐧𝐝 𝐏𝐡𝐚𝐫𝐦𝐚 𝐔𝐩𝐝𝐚𝐭𝐞𝐬: December 8 - 9, 2024 Gotta catch'em all (hematology clinical updates) at ASH 2024, Dimension's $500M second fund at the “interfaces of life science and technology”, Citryll's €85M Series B fuels inflammatory disease ambitions, Agios' discloses liver injuries from "very safe" mitapivat + 37 more stories Get the full TLDR Biotech newsletter here: https://lnkd.in/g_h7_NWS

𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐚𝐧𝐝 𝐏𝐡𝐚𝐫𝐦𝐚 𝐔𝐩𝐝𝐚𝐭𝐞𝐬: December 5 - 8, 2024 Novo Holdings' Catalent acquisition gets go-ahead from EU regulators, Teva & Takeda divest generics joint venture to PE firm, bluebird bio touts positive long-term sickle cell disease gene therapy data, National Resilience layoffs + 24 more stories Get the full TLDR Biotech newsletter here: https://lnkd.in/gGhD7A_F